Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Cash from Financing Activities: 2009-2024

Historic Cash from Financing Activities for Select Medical Holdings (SEM) over the last 16 years, with FY2024 value amounting to -$311.2 million.

  • Select Medical Holdings' Cash from Financing Activities fell 14293.12% to -$135.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$82.9 million, marking a year-over-year decrease of 182414.73%. This contributed to the annual value of -$311.2 million for FY2024, which is 498.23% up from last year.
  • Select Medical Holdings' Cash from Financing Activities amounted to -$311.2 million in FY2024, which was up 498.23% from -$327.5 million recorded in FY2023.
  • Select Medical Holdings' Cash from Financing Activities' 5-year high stood at -$34.9 million during FY2022, with a 5-year trough of -$671.5 million in FY2020.
  • For the 5-year period, Select Medical Holdings' Cash from Financing Activities averaged around -$398.5 million, with its median value being -$327.5 million (2023).
  • Per our database at Business Quant, Select Medical Holdings' Cash from Financing Activities crashed by 218223.31% in 2020 and then surged by 9461.06% in 2022.
  • Select Medical Holdings' Cash from Financing Activities (Annual) stood at -$671.5 million in 2020, then increased by 3.6% to -$647.4 million in 2021, then surged by 94.61% to -$34.9 million in 2022, then tumbled by 838.61% to -$327.5 million in 2023, then grew by 4.98% to -$311.2 million in 2024.
  • Its Cash from Financing Activities stands at -$311.2 million for FY2024, versus -$327.5 million for FY2023 and -$34.9 million for FY2022.